Get the Stockscreener App
1.20
4.35%
+0.05
After Hours:
1.22
0.02
+1.67%
Rigel Pharmaceuticals Stock (RIGL) Forecast
The Rigel Pharmaceuticals (RIGL) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.1817, representing a -1.53% decrease from the current price of $1.20. The highest analyst price target is $1.4686, and the lowest is $0.8947.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RIGL Price Target
Average 1.1275
(-6.05% Downside)
Is Rigel Pharmaceuticals (RIGL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 51.53 | Neutral |
| STOCH(9,6) | 57.04 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0506 | Buy |
| ADX(14) | 31.48 | Sell |
| William %R | -9.5238 | Sell |
| CCI(14) | 201.07 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.1155
Buy
|
1.1288
Buy
|
| MA20 |
1.1423
Buy
|
1.1613
Buy
|
| MA50 |
1.3173
Sell
|
1.2339
Sell
|
| MA100 |
1.3028
Sell
|
1.2455
Sell
|
| MA200 |
1.1798
Buy
|
1.2624
Sell
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, RIGL could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on RIGL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 51.53 indicates that RIGL is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 57.04 indicates that RIGL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that RIGL is oversold. This suggests that RIGL price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.48 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 201.07 indicates that RIGL is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term RIGL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Rigel Pharmaceuticals financial reports and earnings history, Rigel Pharmaceuticals (RIGL) stock could reach $0.0806 by 2030, $0.8123 by 2040 and $1.481 by 2050. See the projected annual prices until 2050 of the Rigel Pharmaceuticals stock below:
- Rigel Pharmaceuticals (RIGL) is expected to reach an average price of $0.1761 in 2035, with a high prediction of $0.4017 and a low estimate of $0.386. This indicates an $-85.33% rise from the last recorded price of $1.20.
- Rigel Pharmaceuticals (RIGL) stock is projected to chart a bullish course in 2040, with an average price target of $0.8923, representing an $-25.64% surge from its current level. The forecast ranges from a conservative $0.8632 to a sky-high $0.8123.
- Our analysts predict Rigel Pharmaceuticals (RIGL) to jump 51.08% by 2045, soaring from $1.7813 to an average price of $1.813, potentially reaching $1.703. While $1.7813 is the low estimate, the potential upside is significant.
- Rigel Pharmaceuticals (RIGL) stock is expected to climb by 2050, reaching an average of $0.5619, a $-53.18% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1.481 and $1.0012, respectively, highlighting the market's uncertainty.
Rigel Pharmaceuticals Stock (RIGL) Year by Year Forecast
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2024
Our forecast for RIGL stock price in 2024 now indicates an average price target of $1.1068 with a high forecast of $1.73 and a low forecast of $0.4836. The average prediction reflects an decrease of -7.77% from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $1.4386 | $0.8947 | $1.4686 | +19.88% |
| July, 2024 | $1.2183 | $1.0983 | $1.5755 | +1.53% |
| August, 2024 | $0.7011 | $0.6961 | $1.2253 | -41.58% |
| September, 2024 | $0.5989 | $0.52 | $0.7819 | -50.09% |
| October, 2024 | $0.5536 | $0.4836 | $0.8597 | -53.87% |
| November, 2024 | $1.1914 | $0.5155 | $1.2814 | -0.72% |
| December, 2024 | $1.1041 | $0.9841 | $1.3872 | -7.99% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2025
Rigel Pharmaceuticals Stock (RIGL) is expected to reach an average price of $1.9847 in 2025, with a high prediction of $3.7691 and a low estimate of $0.2002. This indicates an +65.39% rise from the last recorded price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.9889 | $0.923 | $1.3011 | -17.60% |
| February, 2025 | $1.2416 | $0.9658 | $2.0547 | +3.47% |
| March, 2025 | $1.0194 | $0.8644 | $1.5286 | -15.05% |
| April, 2025 | $0.5041 | $0.2002 | $1.2913 | -57.99% |
| May, 2025 | $0.6119 | $0.3361 | $0.8399 | -49.01% |
| June, 2025 | $0.7547 | $0.5438 | $1.0397 | -37.11% |
| July, 2025 | $0.7894 | $0.7474 | $1.1474 | -34.22% |
| August, 2025 | $0.7872 | $0.7463 | $1.1372 | -34.40% |
| September, 2025 | $1.5949 | $0.9292 | $3.7691 | +32.91% |
| October, 2025 | $1.3346 | $1.1646 | $1.7669 | +11.22% |
| November, 2025 | $1.4324 | $1.2055 | $1.9285 | +19.37% |
| December, 2025 | $1.5221 | $1.3744 | $1.8302 | +26.85% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2026
The predicted value for Rigel Pharmaceuticals (RIGL) in 2026 is set at an average of $3.0246. Estimates vary from a peak of $4.5752 to a trough of $1.4741, indicating an +152.05% surge from the present price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.1599 | $1.4741 | $2.2099 | +79.99% |
| February, 2026 | $2.7877 | $1.9838 | $2.8977 | +132.31% |
| March, 2026 | $2.8255 | $2.3955 | $3.1055 | +135.46% |
| April, 2026 | $3.7352 | $2.4193 | $4.5752 | +211.27% |
| May, 2026 | $3.073 | $2.2791 | $4.1471 | +156.08% |
| June, 2026 | $2.3507 | $2.3107 | $3.2649 | +95.89% |
| July, 2026 | $2.8104 | $2.1054 | $3.1504 | +134.20% |
| August, 2026 | $3.1282 | $2.6643 | $3.2882 | +160.68% |
| September, 2026 | $3.4279 | $3.1279 | $3.7341 | +185.66% |
| October, 2026 | $2.9457 | $2.8057 | $3.4899 | +145.48% |
| November, 2026 | $2.9335 | $2.5677 | $3.1877 | +144.46% |
| December, 2026 | $2.7832 | $2.7582 | $3.3754 | +131.93% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Rigel Pharmaceuticals (RIGL) is $1.4477, with a high forecast of $2.7671 and a low forecast of $0.1284. This indicates an +20.64% increase from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.391 | $2.341 | $2.7671 | +99.25% |
| February, 2027 | $2.2088 | $1.8988 | $2.7549 | +84.06% |
| March, 2027 | $1.7685 | $1.4685 | $2.2107 | +47.37% |
| April, 2027 | $1.5962 | $1.4462 | $2.0924 | +33.02% |
| May, 2027 | $1.664 | $1.3982 | $1.784 | +38.67% |
| June, 2027 | $2.2337 | $1.3848 | $2.3237 | +86.14% |
| July, 2027 | $2.1915 | $2.0476 | $2.7126 | +82.63% |
| August, 2027 | $1.8793 | $1.8693 | $2.4804 | +56.61% |
| September, 2027 | $1.109 | $0.999 | $1.9812 | -7.58% |
| October, 2027 | $0.3268 | $0.1284 | $1.1329 | -72.77% |
| November, 2027 | $0.6145 | $0.1987 | $0.6345 | -48.79% |
| December, 2027 | $0.7843 | $0.3484 | $0.8723 | -34.64% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2028
In 2028, Rigel Pharmaceuticals (RIGL) is projected to reach an average price of $0.6697, with a high projection of $1.3367 and a low estimate of $0.0027. This indicates an -44.19% fall from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.682 | $0.5951 | $1.0062 | -43.16% |
| February, 2028 | $0.4398 | $0.3279 | $0.754 | -63.35% |
| March, 2028 | $0.00187 | $0.0199 | $0.5118 | -99.84% |
| April, 2028 | $0.0282 | $0.0027 | $0.0895 | -97.65% |
| May, 2028 | $0.517 | $0.0488 | $0.8351 | -56.91% |
| June, 2028 | $1.2948 | $0.4809 | $1.3298 | +7.90% |
| July, 2028 | $0.9526 | $0.8706 | $1.3367 | -20.62% |
| August, 2028 | $0.8973 | $0.7365 | $1.1423 | -25.23% |
| September, 2028 | $0.5701 | $0.4701 | $1.0342 | -52.49% |
| October, 2028 | $0.5078 | $0.4259 | $0.6339 | -57.68% |
| November, 2028 | $0.7376 | $0.4498 | $1.2917 | -38.54% |
| December, 2028 | $0.6353 | $0.6053 | $1.1134 | -47.06% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2029
The 2029 price forecast for Rigel Pharmaceuticals Stock (RIGL) is $0.6185 on average, with a high prediction of $1.157 and a low estimate of $0.08. This represents an -48.46% decrease from the previous price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.735 | $0.5888 | $0.7773 | -38.75% |
| February, 2029 | $0.5328 | $0.4409 | $0.747 | -55.60% |
| March, 2029 | $0.5106 | $0.4406 | $0.5948 | -57.45% |
| April, 2029 | $0.3186 | $0.2884 | $0.5545 | -73.45% |
| May, 2029 | $0.206 | $0.0943 | $0.3803 | -82.83% |
| June, 2029 | $0.4859 | $0.1401 | $0.5389 | -59.51% |
| July, 2029 | $0.8536 | $0.4478 | $0.9886 | -28.86% |
| August, 2029 | $0.5833 | $0.5833 | $0.9356 | -51.39% |
| September, 2029 | $0.7411 | $0.4982 | $0.7611 | -38.24% |
| October, 2029 | $0.8508 | $0.7289 | $1.157 | -29.10% |
| November, 2029 | $0.5186 | $0.4486 | $0.9378 | -56.78% |
| December, 2029 | $0.035 | $0.08 | $0.6106 | -97.08% |
Rigel Pharmaceuticals Stock (RIGL) Price Forecast for 2030
Rigel Pharmaceuticals Stock (RIGL) is expected to reach an average price of $0.5058 in 2030, with a high forecast of $1.0094 and a low forecast of $0.00216. This signifies an -57.85% decrease from the last price of $1.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.1306 | $0.1161 | $0.0806 | -89.12% |
| February, 2030 | $0.345 | $0.0328 | $0.4661 | -71.25% |
| March, 2030 | $0.0345 | $0.00336 | $0.3589 | -97.13% |
| April, 2030 | $0.4639 | $0.1356 | $0.3439 | -61.34% |
| May, 2030 | $0.3245 | $0.3845 | $0.4323 | -72.96% |
| June, 2030 | $0.0389 | $0.5206 | $0.4278 | -96.76% |
| July, 2030 | $0.1855 | $0.0316 | $0.2805 | -84.54% |
| August, 2030 | $0.014 | $0.00216 | $0.3244 | -98.84% |
| September, 2030 | $0.00159 | $0.0834 | $0.0916 | -99.87% |
| October, 2030 | $0.156 | $0.0495 | $1.0094 | -87.00% |
| November, 2030 | $0.4609 | $0.00731 | $0.2949 | -61.59% |
| December, 2030 | $0.6179 | $0.5918 | $0.4879 | -48.51% |
1.62%
0.15%
Cap:
|
Volume (24h):